Profile data is unavailable for this security.
About the company
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment includes blood collection and processing devices and disposables for red cells, platelets and whole blood. The Company’s Hospital segment consists of Interventional Technologies, which includes vascular closure devices and sensor-guided technologies, and Blood Management Technologies, which includes devices and methodologies for measuring coagulation characteristics of blood, and blood transfusion management software, among others.
- Revenue in USD (TTM)1.36bn
- Net income in USD123.81m
- Incorporated1985
- Employees3.66k
- LocationHaemonetics Corp125 Summer StreetBOSTON 02110United StatesUSA
- Phone+1 (781) 848-7100
- Websitehttps://www.haemonetics.com
More ▼
Mergers & acquisitions
| Acquired company | HAE:NYQ since announced | Transaction value |
|---|---|---|
| Advanced Cooling Therapy Inc | 14.19% | 160.00m |
Data delayed at least 15 minutes, as of Nov 22 2024 17:05 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quidelortho Corp | 2.82bn | -1.87bn | 2.55bn | 7.10k | -- | 0.799 | -- | 0.9044 | -27.89 | -27.89 | 42.04 | 47.42 | 0.3674 | 2.62 | 7.84 | 396,859.20 | -24.34 | 11.34 | -27.75 | 12.91 | 47.62 | 62.71 | -66.25 | 20.93 | 0.8134 | 0.7419 | 0.4446 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
| Enovis Corp | 2.00bn | -121.38m | 2.58bn | 6.55k | -- | 0.7745 | 17.63 | 1.29 | -2.21 | -2.17 | 36.43 | 59.61 | 0.4023 | 1.59 | 5.91 | 305,598.20 | -2.43 | -0.3569 | -2.66 | -0.41 | 56.96 | 48.19 | -6.03 | -1.06 | 1.12 | 0.9889 | 0.2876 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| TransMedics Group Inc | 401.09m | 32.64m | 2.66bn | 584.00 | 84.50 | 12.68 | 52.79 | 6.64 | 0.9389 | 0.9389 | 11.60 | 6.25 | 0.5439 | 3.56 | 5.32 | 686,797.90 | 4.43 | -16.08 | 4.78 | -17.95 | 59.34 | 65.37 | 8.14 | -40.47 | 7.33 | -- | 0.7078 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| Warby Parker Inc | 742.53m | -32.56m | 2.80bn | 2.14k | -- | 8.31 | 246.87 | 3.77 | -0.2731 | -0.2731 | 6.20 | 2.80 | 1.22 | 5.70 | 818.21 | 346,975.20 | -5.37 | -- | -6.78 | -- | 55.32 | 57.49 | -4.39 | -14.53 | 2.06 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| LivaNova PLC | 1.24bn | 23.68m | 2.81bn | 2.90k | 121.38 | 2.14 | 41.37 | 2.26 | 0.4259 | 0.4259 | 22.81 | 24.13 | 0.5119 | 2.47 | 6.42 | 428,185.90 | 0.9777 | -6.01 | 1.12 | -7.42 | 67.78 | 66.99 | 1.91 | -13.56 | 2.87 | 2.46 | 0.3234 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
| Inari Medical Inc | 574.50m | -78.58m | 2.91bn | 1.30k | -- | 6.69 | -- | 5.07 | -1.35 | -1.35 | 9.90 | 7.44 | 0.9221 | 1.59 | 7.46 | 441,921.50 | -12.61 | -0.5941 | -15.24 | -0.6696 | 86.82 | 89.06 | -13.68 | -0.6295 | 1.40 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
| Neogen Corp | 912.20m | -23.53m | 3.16bn | 2.92k | -- | 1.01 | 33.52 | 3.46 | -0.1086 | -0.1086 | 4.21 | 14.47 | 0.2013 | 2.71 | 5.98 | 312,718.20 | -0.5193 | 1.38 | -0.5346 | 1.44 | 49.56 | 48.23 | -2.58 | 4.31 | 2.79 | 1.03 | 0.2215 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
| Envista Holdings Corp | 2.50bn | -1.34bn | 3.68bn | 12.80k | -- | 1.20 | -- | 1.47 | -7.77 | -7.77 | 14.51 | 17.86 | 0.4106 | 4.21 | 6.19 | 195,570.30 | -21.93 | 1.94 | -25.27 | 2.34 | 54.20 | 57.65 | -53.42 | 5.29 | 1.77 | 3.13 | 0.3163 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| DENTSPLY SIRONA Inc | 3.90bn | -413.00m | 3.71bn | 15.00k | -- | 1.49 | -- | 0.9501 | -2.07 | -2.07 | 18.91 | 12.53 | 0.5641 | 2.94 | 5.91 | 260,000.00 | -5.93 | -1.14 | -7.41 | -1.32 | 52.18 | 53.65 | -10.51 | -2.51 | 0.8444 | 3.21 | 0.471 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| Guardant Health Inc | 692.26m | -512.41m | 3.83bn | 1.78k | -- | -- | -- | 5.53 | -4.24 | -4.24 | 5.70 | -0.488 | 0.415 | 3.68 | 7.81 | 389,126.50 | -30.72 | -22.26 | -35.19 | -24.59 | 60.31 | 64.62 | -74.02 | -97.07 | 5.85 | -8.04 | 1.06 | -- | 25.45 | 44.14 | 26.76 | -- | 0.2786 | -- |
| ICU Medical Inc | 2.34bn | -111.01m | 4.12bn | 14.00k | -- | 2.02 | 36.20 | 1.76 | -4.57 | -4.57 | 96.31 | 83.76 | 0.5391 | 2.16 | 13.94 | 167,149.80 | -2.56 | 1.46 | -2.90 | 1.65 | 32.87 | 34.11 | -4.74 | 2.23 | 1.03 | 0.5158 | 0.4382 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Haemonetics Corporation | 1.36bn | 123.81m | 4.29bn | 3.66k | 35.48 | 4.90 | 18.39 | 3.15 | 2.41 | 2.41 | 26.48 | 17.44 | 0.6001 | 1.87 | 7.02 | 372,224.00 | 5.46 | 5.02 | 6.19 | 6.07 | 54.02 | 51.74 | 9.10 | 8.11 | 2.09 | 27.43 | 0.5823 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
| Integer Holdings Corp | 1.68bn | 114.44m | 4.56bn | 10.50k | 41.89 | 2.81 | 20.60 | 2.71 | 3.24 | 3.22 | 47.87 | 48.33 | 0.5594 | 4.93 | 5.14 | 160,023.80 | 3.81 | 3.28 | 4.10 | 3.53 | 27.06 | 26.94 | 6.81 | 6.40 | 2.09 | 4.11 | 0.4028 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| Procept Biorobotics Corp | 199.84m | -100.06m | 5.11bn | 626.00 | -- | 20.42 | -- | 25.55 | -1.95 | -1.95 | 3.89 | 4.63 | 0.5026 | 1.83 | 3.86 | 319,238.00 | -25.16 | -- | -28.58 | -- | 57.39 | -- | -50.07 | -- | 5.07 | -- | 0.1758 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| Inspire Medical Systems Inc | 755.59m | 33.05m | 5.58bn | 1.01k | 171.11 | 8.01 | 146.81 | 7.38 | 1.09 | 1.09 | 25.15 | 23.25 | 1.05 | 2.46 | 9.37 | 747,372.90 | 4.60 | -11.27 | 5.12 | -12.60 | 84.77 | 84.47 | 4.37 | -13.57 | 6.94 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Stevanato Group SpA | 1.15bn | 120.12m | 5.94bn | 5.64k | 43.86 | 3.87 | 29.38 | 5.19 | 0.4473 | 0.4473 | 4.26 | 5.07 | 0.5284 | 2.75 | 2.66 | 203,340.60 | 5.54 | -- | 7.39 | -- | 29.20 | -- | 10.48 | -- | 1.21 | 48.53 | 0.2148 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Haemonetics Corp's reporting currency: US Dollar USD
61.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2024 | 5.60m | 10.95% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 5.02m | 9.81% |
| Capital Research & Management Co. (Global Investors)as of 30 Sep 2024 | 4.44m | 8.68% |
| Neuberger Berman Investment Advisers LLCas of 30 Sep 2024 | 4.03m | 7.87% |
| Wellington Management Co. LLPas of 30 Sep 2024 | 3.93m | 7.68% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2024 | 2.85m | 5.57% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 1.89m | 3.69% |
| Royce & Associates LPas of 30 Sep 2024 | 1.21m | 2.37% |
| Geode Capital Management LLCas of 30 Sep 2024 | 1.19m | 2.33% |
| Thrivent Asset Management LLCas of 30 Sep 2024 | 1.10m | 2.15% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
